|   |   | 
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/535 | |||
| A61K 31/5575 | |||
| A61K 31/542 | |||
| A61K 45/06 | |||
| A61K 31/215 | 
| (11) | Number of the document | 3042646 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 15202422.0 | 
| Date of filing the European patent application | 2009-03-13 | |
| (97) | Date of publication of the European application | 2016-07-13 | 
| (45) | Date of publication and mention of the grant of the patent | 2017-05-10 | 
| (46) | Date of publication of the claims translation | 
| (30) | Number | Date | Country code | 
| 37117 P | 2008-03-17 | US | |
| 111920 P | 2008-11-06 | US | 
| (72) | 
                    
                    
                    
                    
                    KABRA, Bhagwati, P., US  
                    
                    
                    
                    
                    CARRERAS, Nuria, ES  
                    
                    
                    
                    
                    GAL N, Francisco, Javier, ES  
                    
                    
                    
                    
                    NARDA, Mridvika, ES  
                    
                    
                    
                    
                    PUIG GONZ LEZ, Elena, ES  
                    
                    
                    
                    
                    JIMÉNEZ, Nuria, ES  
                    
                    
                    
                    
                    MART NEZ, Carmen, ES  
                    
                    
                    
                    
                    CUCHI, M nica, ES  | 
| (73) | Alcon Research, Ltd.,
                6201 South Freeway, Fort Worth, TX 76134-2099,
                US | 
| (54) | PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY | 
| PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY |